Vertex Pharmaceuticals
VRTX
VRTX
1,513 hedge funds and large institutions have $90.7B invested in Vertex Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 143 funds opening new positions, 547 increasing their positions, 614 reducing their positions, and 154 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
11% less repeat investments, than reductions
Existing positions increased: 547 | Existing positions reduced: 614
15% less capital invested
Capital invested by funds: $107B → $90.7B (-$16.4B)
56% less funds holding in top 10
Funds holding in top 10: 16 → 7 (-9)
Holders
1,513
Holding in Top 10
7
Calls
$846M
Puts
$533M
Top Buyers
| 1 | +$858M | |
| 2 | +$467M | |
| 3 | +$236M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$218M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
+$186M |
Top Sellers
| 1 | -$1.3B | |
| 2 | -$1.18B | |
| 3 | -$1.13B | |
| 4 |
Edgewood Management
Greenwich,
Connecticut
|
-$404M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$326M |
